相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
Kathy S. Albain et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Predictive model of aromatase inhibitor non-adherence using patient-reported outcomes in women with breast cancer (SWOG S1105).
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Residential mobility among adult cancer survivors in the United States
Bian Liu et al.
BMC PUBLIC HEALTH (2020)
The Coronavirus Disease 2019 (COVID-19) Pandemic: A Patient-Centered Model of Systemic Shock and Cancer Care Adherence
Ruth C. Carlos et al.
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2020)
Oncology clinical trials and insurance coverage: An update in a tenuous insurance landscape
Samilia Obeng-Gyasi et al.
CANCER (2019)
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Joseph A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pilot Feasibility Study of an Oncology Financial Navigation Program in Brain Cancer Patients
Gelareh Sadigh et al.
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2019)
The impact of state parity laws on copayments for and adherence to oral endocrine therapy for breast cancer
Alexander L. Chin et al.
CANCER (2019)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer
Gretchen G. Kimmick et al.
JOURNAL OF GERIATRIC ONCOLOGY (2018)
Value of Neighborhood Socioeconomic Status in Predicting Risk of Outcomes in Studies That Use Electronic Health Record Data
Nrupen A. Bhavsar et al.
JAMA NETWORK OPEN (2018)
Health Care Price Transparency and Communication: Implications for Radiologists and Patients in an Era of Expanding Shared Decision Making
Gelareh Sadigh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
The Effects of the Transition From Medicaid to Medicare on Health Care Use for Adults With Mental Illness
Marguerite E. Burns et al.
MEDICAL CARE (2016)
Race, Neighborhood Economic Status, Income Inequality and Mortality
Nicolle A. Mode et al.
PLOS ONE (2016)
Improving Adjuvant Hormone Therapy Use in Medicaid Managed Care-Insured Women, New York State, 2012-2014
Victoria L. Wagner et al.
PREVENTING CHRONIC DISEASE (2016)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Evaluating Area-Based Socioeconomic Status Indicators for Monitoring Disparities within Health Care Systems: Results from a Primary Care Network
Seth A. Berkowitz et al.
HEALTH SERVICES RESEARCH (2015)
Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up
Renee Simon et al.
CANADIAN JOURNAL OF SURGERY (2014)
Adherence to Endocrine Therapy in Breast Cancer Adjuvant and Prevention Settings
Rowan T. Chlebowski et al.
CANCER PREVENTION RESEARCH (2014)
The Change From Brand-Name to Generic Aromatase Inhibitors and Hormone Therapy Adherence for Early-Stage Breast Cancer
Dawn L. Hershman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Endocrine therapy initiation among Medicaid-insured breast cancer survivors with hormone receptor-positive tumors
Stephanie Brooke Wheeler et al.
JOURNAL OF CANCER SURVIVORSHIP (2014)
A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: summarizing the data for clinicians
Laetitia Huiart et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
Caitlin C. Murphy et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Influence of Race, Insurance, Socioeconomic Status, and Hospital Type on Receipt of Guideline-Concordant Adjuvant Systemic Therapy for Locoregional Breast Cancers
Xiao-Cheng Wu et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Initiation of Adjuvant Hormone Therapy by Medicaid Insured Women With Nonmetastatic Breast Cancer
Rachel L. Yung et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Racial and Ethnic Differences in Adjuvant Hormonal Therapy Use
Jennifer C. Livaudais et al.
JOURNAL OF WOMENS HEALTH (2012)
Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer
Alfred I. Neugut et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Adherence to long-term adjuvant hormonal therapy for breast cancer
Carolyn Gotay et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Disparities in Medical Care Among Commercially Insured Patients With Newly Diagnosed Breast Cancer Opportunities for Intervention
Louise J. Short et al.
CANCER (2010)
American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Patient Adherence and Persistence With Oral Anticancer Treatment
Kathryn Ruddy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Insurance Disruption due to Spousal Medicare Transitions: Implications for Access to Care and Health Care Utilization for Women Approaching Age 65
Jessica R. Schumacher et al.
HEALTH SERVICES RESEARCH (2009)
Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients
Aye Moe Thu et al.
AMERICAN JOURNAL OF SURGERY (2008)
Adherence to oral endocrine therapy for breast cancer: A nursing perspective
Christine Miaskowski et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2008)
Early discontinuation of tamoxifen - A lesson for oncologists
Thomas I. Barron et al.
CANCER (2007)
Adherence to endocrine therapy for breast cancer
Rowan T. Chlebowski et al.
ONCOLOGY (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: Treatment results of intergroup protocol INT-0102
LF Hutchins et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
AW Fyles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women
AW Prehn et al.
CANCER (2002)
Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women
S Demissie et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
